Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
Home
Publications
Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
Authors:
QL
Qiaoying Lv
Qiaoying Lv
TS
Tong Su
Tong Su
WL
Wei Liu
Wei Liu
LW
Lulu Wang
Lulu Wang
JH
Jiali Hu
Jiali Hu
YC
Yali Cheng
Yali Cheng
CN
Chengcheng Ning
Chengcheng Ning
WS
Weiwei Shan
Weiwei Shan
XL
Xuezhen Luo
Xuezhen Luo
XC
Xiaojun Chen
Xiaojun Chen
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
17 June 2026
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/2326-6066.32701520
Abstract
Supplementary Figure S3. ApoA1 exerts its antitumor activity in a CD8 +T cell–dependent manner (related to Figure 3)
Keywords
GYNECOLOGICAL CANCERS
IMMUNOTHERAPY
CHECKPOINT BLOCKADE
TUMOR MICROENVIRONMENT
Related articles
Scroll to top